Question

Which countries run stem-cell trials for Male Infertility?

10 countries host at least one registered site; Egypt alone accounts for around 27% of mentions in this snapshot (2026-08-29).

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

Country distribution

CountryStudies with a site there
Egypt4
United States3
Israel1
Russia1
United Arab Emirates1
Brazil1
Spain1
Jordan1
Antigua and Barbuda1
Belgium1

A study with sites in several countries is counted once per country, taken from the location block of each registry record.

What the map means for Male Infertility

Registered activity follows academic andrology and IVF research centres, while commercial offers cluster around fertility-tourism markets. Success-rate claims in that commercial space frequently mix cell therapy with concurrent IVF-ICSI, making attribution impossible.

Where recruitment is actually open

CountryOpen studies with a site there
United States2
United Arab Emirates1
Jordan1

What travelling for a trial actually involves

Travelling to a trial site is not like booking a treatment package. Sites enrol people they can follow up, which usually means repeated visits over months, local imaging or bloods, and an emergency route if something goes wrong. Ask about all three before booking anything.

Multi-country studies, named

Registered studies with sites in more than one country — the clearest evidence of collaboration rather than a single-centre series.

No sampled study for this condition lists sites in more than one country, so the research base here is made of single-centre work rather than multinational collaboration.

Why trial geography is not a shortlist

Where studies happen reflects who funds and who authorises them. Treating that as a ranking of care quality confuses the research system with the treatment market, two things that overlap far less than medical-tourism marketing implies.

Before treating geography as a shortlist, read the legality overview by country and what "best country" actually means here.

When these studies started

Registrations by start year since 2020: 2023 (1), 2024 (1), 2025 (3). Activity for this condition spans 2009 to 2025, which shows whether interest is growing, flat or past its peak.

Frequently asked

Which countries run stem-cell trials for Male Infertility?

Sites are registered in 10 countries; the largest is Egypt (~27% of country mentions, 2026-08-29).

Does a country with many trials mean better treatment there?

It does not follow. A country can host many trials and still have an unregulated commercial sector selling something quite different to visitors.

Are trial sites and commercial clinics the same thing?

Rarely. Academic trial sites and the private clinics advertising to medical tourists are typically separate organisations with different oversight.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads